ConductScience.org, home

Paper591982

Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.

Caraceni TA and 3 others. J Neurol Neurosurg Psychiatry, 1977. Cited by 28 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease. Papers, record 591982. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/591982

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.
PubMed
Journal
J Neurol Neurosurg Psychiatry
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.89
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Caraceni TAT A
2Celano II
3Parati EE
4Girotti FF

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenserazideMajor topic
BromocriptineMajor topic
HydrazinesMajor topic
LevodopaMajor topic
Parkinson DiseaseMajor topic
Aged
Drug Evaluation
Drug Therapy, Combination
Female
Humans
Male
Middle Aged

Source PubMed

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1319,421[Treatment of parkinsonian syndromes by bromocriptin].Nouv Presse Med1977https://conductscience.org/library/papers/319421PubMed
2989,885Treatment of parkinson's disease with bromocriptine.N Engl J Med1976https://conductscience.org/library/papers/989885PubMed
3945,489Studies with bromocriptine. Part 1. "On-off" phenomena.Neurology1976https://conductscience.org/library/papers/945489PubMed
44,425,916Bromocriptine in Parkinsonism.Br Med J1974https://conductscience.org/library/papers/4425916PubMed
54,154,991Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys.J Pharm Pharmacol1974https://conductscience.org/library/papers/4154991PubMed
6166,332Studies on the antiparkinsonism efficacy of lergotrile.Neurology1975https://conductscience.org/library/papers/166332PubMed
74,146,398Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.J Pharm Pharmacol1973https://conductscience.org/library/papers/4146398PubMed
859,850Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.Lancet1976https://conductscience.org/library/papers/59850PubMed
9181,692Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.Neurology1976https://conductscience.org/library/papers/181692PubMed
10167,567Modification of involuntary movements by centrally acting drugs.Adv Neurol1975https://conductscience.org/library/papers/167567PubMed
11817,221The antiparkinsonian efficacy of bromocriptine.Neurology1976https://conductscience.org/library/papers/817221PubMed
12772,175Bromocriptine treatment in Parkinson's disease.J Neurol Neurosurg Psychiatry1976https://conductscience.org/library/papers/772175PubMed
13773,080Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.Acta Neurol Scand1976https://conductscience.org/library/papers/773080PubMed
14778,655Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.Neurology1976https://conductscience.org/library/papers/778655PubMed
155,104,054Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-Ergokryptine (CB 154).Experientia1971https://conductscience.org/library/papers/5104054PubMed
165,752,992[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat].Experientia1968https://conductscience.org/library/papers/5752992PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
6,862,842Bromocriptine--lisuride cross tolerance.Ital J Neurol Sci1983https://conductscience.org/library/papers/6862842PubMed
6,435,991Anti-parkinsonian drugs today.Drugs1984https://conductscience.org/library/papers/6435991PubMed
6,180,142Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.J Neurol1982https://conductscience.org/library/papers/6180142PubMed
3,063,495Therapeutic applications of bromocriptine in endocrine and neurological diseases.Drugs1988https://conductscience.org/library/papers/3063495PubMed
39,308Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/39308PubMed
37,066Bromocriptine in the treatment of parkinsonism.Drugs1979https://conductscience.org/library/papers/37066PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/591982

GET https://conductscience.org/api/papers/v1/591982/authors